USPTO serial 99792682
PEVYKOR
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- SPARACINO, MARK V
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PEVYKOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rosaleen H. Chou
Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of liver-related diseases; Pharmaceutical preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of chronic hepatitis B virus (HBV) infection; Pharmaceutical preparations for the treatment of chronic hepatitis D virus infection; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the treatment of rare viral diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for viral diseases; Therapeutic biological preparations for the treatment of viral diseases, liver-related diseases, metabolic diseases, chronic hepatitis B virus (HBV) infections, chronic hepatitis D virus (HDV) infections, and rare viral diseases | ACTIVE | — |
| 042 | Scientific research in the field of virology and hepatology; Research and development in the field of pharmaceutical research and development; Pharmaceutical research in the field of antiviral therapeutics; Drug discovery services; Pharmaceutical drug development services; Research and development services in the field of pharmaceutical preparations; Research and development of new products in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Clinical research in the field of treatment of viral, liver, and metabolic diseases; Medical and scientific research in the field of viral, liver, and metabolic diseases; Scientific research in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2026 | NWAP | NEW APPLICATION ENTERED | — |